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Beneﬁts and risks of antimicrobial drugs, used in food-producing animals, continue to
be complex and controversial issues. This review comprehensively presents the beneﬁts
of antimicrobials drugs regarding control of animal diseases, protection of public health,
enhancement of animal production, improvement of environment, and effects of the
drugs on biogas production and public health associated with antimicrobial resistance.
The positive and negative impacts, due to ban issue of antimicrobial agents used in food-
producing animals, are also included in the discussion. As a double-edged sword, use of
these drugs in food-animals persists as a great challenge.
Keywords: antimicrobial drug, benefit, risk, animal food production, public health
INTRODUCTION
Over the decades, world population tremendously increased to 7
billion (Food and Agriculture Organization [FAO], 2012) and 870
million (12.5%) of them were estimated to be undernourished
during 2010–2012 (Food and Agriculture Organization [FAO],
2012; Krehbiel, 2013). Demand for animal source food tends to
be soaring day by day, especially in developing countries (Food
and Agriculture Organization [FAO], 2009; Krehbiel, 2013). It
is acknowledged that the antimicrobial use is one of the most
successful chemotherapies. Various antimicrobials have made sig-
niﬁcant contribution for the prevention, control, and treatment
of infectious diseases in animals since 1940s (Forman and Burch,
1947). Low and sub-therapeutic dose of antimicrobials plays very
important role for the improvement of feed efﬁciency, promo-
tion of animal growth, and prevention and control of the diseases
(Dibner and Richards, 2005; Niewold, 2007). Internationalmarket
value of veterinary drugs (including antimicrobials) tremendously
increased from $8.65 billion in 1992 to $20.1 billion in 2010 and in
2018, it is expected to increase to $42.9 billion (GIA, 2012; Reports,
2012).
It is undeniable that rational use of antimicrobials plays
a vital role in the production of food animals and protect-
ing public health, while irrational and irresponsible use may
cause antimicrobial resistance. On the basis of “Swan Reports”
in 1969, Great British took ﬁrst action for the restriction of
antibiotics, being used in animals or capable of cross-resisting
with antibiotics used in human medicine. In 1973, the Euro-
pean Community (EC) commenced the withdrawal of some
important antibiotic use as growth promoters in animal feed.
After that, Sweden banned the use of all growth-promoting
antibiotics in 1986. Avoparcin, bacitracin, spiramycin, tylosin,
and virginiamycin were withdrawn as growth promoters in the
European Union (EU) from 1995 to 1999, on the basis of pre-
cautionary principle. In 2006, all the uses of low-dose antibiotics
(5∼40 ppm) in food animals, including ﬂavomycin, avilamycin,
salinomycin, monensin, and other animal-speciﬁc antibiotics,
were banned in the EU with the intention to avoid their nega-
tive impact of resistant development (EPC, 2005; Marshall and
Levy, 2011).
The beneﬁts and risks of antimicrobials continue to be com-
plex and controversial issues. The risks of antimicrobial drugs
to public health associated with antimicrobial resistance raised
great concern recently, while the beneﬁts of antimicrobial drugs,
such as prevention and treatment of animal diseases, protection of
public health, enhancement of animal production, and improve-
ment of environment, were disregarded most of the time. Many
beneﬁt-related claims have not yet been fully demonstrated in
large-scale trials, and other trials revealed that the overall impact of
the short-term beneﬁts was poorly described. This article presents
the beneﬁts and risks of antimicrobials drugs used in food ani-
mals and discusses the positive and negative effects of the ban on
antimicrobial growth promoters.
BENEFITS OF ANTIMICROBIAL DRUGS
PREVENTION AND TREATMENT OF ANIMAL DISEASES
With intensive animal production, bacterial and parasitic dis-
eases became more and more frequent. According to an estimate,
80 types of bacteria, such as Escherichia coli, Salmonella, and
Clostridium welchii, posed a serious threat to poultry industry.
Mastitis, caused by Staphylococcus aureus in dairy animals, led to
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a loss of $2 billion/year in the United States of America (USA)
and an average cost of €485/dairy cow in the EU during 2012
(Heikkila et al., 2012). Due to infection caused by Streptococcus
pneumonia, morbidity and mortality rates in calves increased to
40 and 20%, respectively (Akkermans andVecht, 1994; Vogel et al.,
2001). More than 50%of aquatic animals were infected by bacteria
each year (Scarfe et al., 2011). Vibrio vulniﬁcus became a potential
health hazard for aquatic animals and human beings (Yano et al.,
2004).
Approximately, 2169 parasites including 203 protozoa, 373
trematodes, 150 tapeworms, 404 nematodes, and 1030 arthropods
have been found in livestock and poultry in China. About 4–20
billion dollars/year (8.3% annual output of animal husbandry)
were lost due to parasitic diseases caused by coccidia, nema-
todes, ticks, and others in USA (Krausse and Schubert, 2010).
Acute outbreaks of chicken coccidiosis paid a loss of 42 million
pounds annually in the United Kingdom (Franklyn et al., 2010).
In China, poultry industry had to face billions of dollars annual
loss due to almost 100% chicken morbidity by coccidiosis (Zhang
et al., 2013). Sheep helminthiasis led to a loss of 2.22 million
dollars annually in Australia (Hosking et al., 2009; Larsen et al.,
2009).
Over one hundred of antimicrobials, including β-lactams,
aminoglycosides, tetracyclines, amphenicols, macrolides, sul-
fonamides, ﬂuoroquinolones, lincosamides, polypeptides, and
polyene, have been used in food-producing animals around the
world. These antimicrobials have played an essential role in the
prevention, treatment, and control of food animal diseases caused
by pathogens, such as pathogenic E. coli, S. aureus, S. pneumonia,
Actinobacillus pleuropneumoniae, mycoplasma, Vibrio, and others
(Hoﬂack et al., 2001; Krausse and Schubert, 2010). It was reported
that in USA, 52.1% of total antimicrobials were used for the treat-
ment of infectious diseases in animals, where 90% of starter pigs,
75% of grower pigs, 50% of ﬁnisher pigs, and 25∼70% of cat-
tle received the drugs through feed (Van Lunen, 2003; USFDA,
2009; GRACE, 2013). With a dose of 40 mg/kg, avilamycin in
feed could remarkably decrease the incidence of diarrhea in post-
weaning pigs (Partanen et al., 2007). When salinomycin was used
in sows and pigs simultaneously, incidence of diarrhea in piglets
was signiﬁcantly reduced and the survival rate was increased by
13.95% (Nagaraja and Taylor, 1987). Sulfonamide and folic acid
supplementation in diet increased live birth rate of piglets by 1%
(Lindemann and Kornegay, 1989). Hence, it is concluded that
the use of antimicrobials is a primary strategy for prevention and
treatment of bacterial infections in food-producing animals.
Many antimicrobials have strong activity against parasites in
animals. Use of sulfonamides in animals opened a new era of
anti-parasitic drugs and made lots of parasitic diseases under
control. Up till now, anti-parasitic drugs have shared about one-
third sale of the global veterinary drug markets. Macrolides and
benzimidazoles effectively controlled nematodes. Doramectin and
ivermectin helped to prevent infection of Argulus siamensis in carp
and Labeo rohita (Hemaprasanth et al., 2012). In rabbit, subcuta-
neous injection of ivermectin, at dose of 400 mg per kg, not only
helped to clinical cure ear mite infection but also prevented loss
of fur and thus, played a vital role for the improvement of fur
production (McKellar et al., 1992).
Conclusively, due to unique advantages, such as exact target-
ing of pathogens, well-known mechanisms of activity and desired
stability, antimicrobials justiﬁed their usage in livestock and
poultry, and played important part for prevention and treatment
of bacterial and parasite diseases.
PROTECTION OF HUMANS AGAINST ZOONOSIS
Among animal infectious and parasitic diseases, more than 200
can affect human life. Campylobacter spp., Salmonella spp., E.
coli O157, Vibrio parahaemolyticus, and Aeromonas hydrophila
from animals pose great health threat to both humans and ani-
mals (Altwegg and Geiss, 1989; Mellata, 2013). The United
States Centers for Disease Control and Prevention (US-CDC)
estimated that there were about 76 million annual cases of food-
borne illness in USA, including 325,000 hospitalizations and 5000
deaths (Mead et al., 1999a). Annual cases of Campylobacter spp.,
Salmonella spp., E. coli O157, and V. parahaemolyticus were
1,963,000, 1,332,000, 62,500, and 5000, respectively (Mead et al.,
1999a,b).
To some extent, antimicrobial agents guaranteed human food
security and public health by controlling animal diseases and
preventing transmission of zoonotic pathogens from animals to
humans. When added to animal feed or drinking water, these
drugs could signiﬁcantly decrease the bacterial contamination
in animal products. For examples, virginiamycin decreased the
contamination of Clostridium perfringens, Campylobacter spp.,
and other food-borne pathogens in animal carcasses (Tice, 2001;
Russell, 2003; Hurd et al., 2005). Salinomycin reduced infec-
tion of type C Clostridium in sows and weaning piglets by 43%
(Nagaraja and Taylor, 1987). Neomycin in animal feed signif-
icantly reduced the number of E. coli O157: H7 in animal
feces, and gentamycin reduced bacterial count in poultry eggs
and meat (Elder et al., 2002; Doyle and Erickson, 2006). When
cattle was fed with neomycin sulfate for 48 h and held for
24-h drug withdrawal period before slaughtering, it shed con-
siderably less E. coli O157:H7 cells than those pen mates who
did not receive the treatment (Elder et al., 2002). A farm-level
study in 2008 by Ohio State University demonstrated that only
39% of hogs, raised on conventional antimicrobial operations,
were infected with Salmonella, while those were 54% in case of
antimicrobial-free operations (Nunes, 2008; AMI, 2010). Flor-
fenicol (10 mg/kg) presented 100% efﬁciency for the treatment
of A. hydrophila of Piaractus mesopotamicus (Carraschi et al.,
2012). Oxytetracycline hydrochloride or norﬂoxacin in bait feed
reduced the number of A. hydrophila in water by 46.86∼66.24%,
indicating that the risk of the bacterial infection to humans be
decreased.
ENHANCEMENT OF ANIMAL PRODUCTION
In 1943, a few farmers in USA found that pigs fed with penicillin-
fermented mixture grew faster (Wahlstrom et al., 1950; Hewes,
1955; Taylor and Gordon, 1955). In 1946, Moore found that
low dose of streptomycin stimulated chick’s growth (Moore
and Evenson, 1946; Dibner and Richards, 2005). Subsequently,
chlortetracycline, doxycycline, and sulfonamides helped growth
promotion in calves, pigs, and chicken. Cunha from Univer-
sity of Florida and Stokstad from University of Washington
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reported that penicillin in fermentation mixture functioned as
a growth promoter for food-animals (Cunha et al., 1951). Legal
use of the antimicrobials in feed has a history of over 60 years.
Food and Drug Administration in USA (US FDA) approved
these drugs as growth promoters for animals in 1951. Till 1978,
47.9% of the antimicrobials were used to be added in animal
feed in USA. About 60% of poultry, 93% of chicken, 97% of
growing pigs, and 80% of fattening pigs received antimicro-
bials through diet during the early 1990s. More than 40% of
the drugs were added in animal feed at subtherapeutic level for
improving animal production in USA during 1990s (Van Lunen,
2003). With a substantial contribution to the development of
food-animal production at global level, veterinary antimicrobials
tend to be necessities to cope with increasing food demand for
humans.
Role of antimicrobials for the improvement of feed con-
version ratio (FCR), animal growth, and reproductive perfor-
mance has been well proven as given in Table 1, and discussed
under following points (Cromwell, 2002). (1) Orally admin-
istered antimicrobials in pigs increased diet digestibility and
improved feed utilization efﬁciency by 1.7∼5.1% and 6.9∼7%,
respectively (Cromwell, 1999; Hardy, 1999; JETACAR, 1999;
Van Lunen, 2003). (2) Addition of the drugs (e.g., chlortetra-
cycline, sulfonamide, folic acid, carbadox, tilmicosin, tylosin,
or sulfamethazine) in feed could remarkably improve the con-
ception rate, farrowing rate, milk secretion, productive efﬁ-
ciency of sow, and live birth rate of piglet (Soma and Speer,
1975; Lindemann and Kornegay, 1989; Alexopoulos et al., 1998;
Kantas et al., 1998; Weber et al., 2001; Partanen et al., 2007).
(3) Feeding antimicrobials to pigs increased their weight gain
by 1.9∼16.4% (Nagaraja and Taylor, 1987; Cromwell, 1999;
JETACAR, 1999; Van Lunen, 2003; IFAH-EuroP, 2005). (4)
Administration of antibiotics (bacitracin zinc, colistin sulfate,
ﬂavomycin, and ﬂorfenicol) in ﬁsh diet signiﬁcantly improved
the feed conversion and promoted their growth (He et al., 2011;
Zhou et al., 2011). (5) Antimicrobial (tiamulin, nosiheptide,
Table 1 | Part of evidences for the role of antimicrobials on feed utilization, growth promotion, reproductive performance, and carcass quality.
Example no Reference Drugs and animals Parameters of animal
production
Increase or
decrease rate
1 Hardy (1999), Van Lunen (2003) Antimicrobials to growing and
fattening pigs
Digestion of energy 5.10%↑
Digestion of nitrogen 1.80%↑
Digestion of phosphorus 3.40%↑
2 Van Lunen (2003) Antimicrobials to swine Feed utilization 7%↑
Average weight gain 3.3–8.8%↑
3 JETACAR (1999), Van Lunen (2003) Antimicrobials to young pigs Feed utilization 4.60%↑
Average weight gain 6.80%↑
Antimicrobials to grower pigs Feed utilization 1.70%↑
Average weight gain 1.90%↓
4 Cromwell (1999), Van Lunen (2003) Antimicrobials to piglet Feed utilization 6.90%↑
5 IFAH-EuroP (2005) Antimicrobials to food animal Average weight gain 4–5%↑
6 Cromwell (1999), Van Lunen (2003) Antimicrobials to piglet Average weight gain 16.40%↑
7 Nagaraja andTaylor (1987) Salinomycin to weanling piglets Average weight gain 15.82%↑
8 He et al. (2011), Zhou et al. (2011) (Bacitracin zinc, colistin sulfate,
Flavomycin and ﬂorfenicol) to
(Carassius, Carp or hybrid tilapia)
Average weight gain 24.5∼40.87%↑
9 Soma and Speer (1975) Chlortetracycline to sow Conception rate 4.10%↑
Farrowing rate 5.80%↑
10 Lindemann and Kornegay (1989) Folic acid to sow Gestation gain 18%↑
11 Cromwell and Stahly (1985),
Cromwell et al. (1984a,b),
Lindemann et al. (1985)
Tiamulin, nosiheptide, and
salinomycin to pig
Thickness of backfat 9.7%↓
Thickness of total fat 8%↓
Eye muscle area 9.80%↑
Lean meat 4.40%↑
↑ Denotes increase, while ↓ denotes decrease.
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salinomycin, and tylosin) supplementation could also improve the
carcass quality by decreasing the fat thickness and increasing the
lean meat of food-producing animals (Cromwell et al., 1984a,b;
Cromwell and Stahly, 1985; Lindemann et al., 1985; Van Lunen,
2003).
A lot of studies were carried out to ﬁnd themechanism involved
inbeneﬁcial aspects of antimicrobials in animals. Jukes, Franti, and
other scientists proved that the drugs attenuated intestinalwall and
improved the digestibility of nutrients (Manson, 1968; Falkow,
1970; Jukes, 1970; Franti et al., 1971, 1972; Dibner and Richards,
2005). Midtvedt (1986) and Norin (1997) conﬁrmed that oral
doses of antimicrobials improved the structure of intestinal ﬂora
(Midtvedt,1986;Norin,1997). Salinomycin and avilamycin in feed
improved the bioavailability of α-tocopheryl acetate in broilers by
altering lipid absorption (Knarreborg et al., 2004). According to a
previous review by Allen et al. (2013), antimicrobials have multi-
functional role in animals, elaborated under following points:
(1) these could reduce the colonization of intestinal bacteria and
inhibit the growth of pathogenic microorganisms; (2) by decreas-
ing the thickness of mucous membrane, led to more absorption of
nutrients and reduced fermentation; (3) they directly neutralized
the host immune response. In short, antimicrobials could affect
the host intestinal ﬂora, intestinal physiology, and immune sys-
tem, and consequently, prevent disease, improve feed conversion,
and enhance the growth of animals (Niewold, 2007). Till now,
there are no appropriate alternatives which can replace antimicro-
bial growth promoters, in case those remain banned. Although
numerous feed additives, mainly pre- and pro-biotic products,
are commercially available now and seem to have potential to
replace these growth promoters, but their true efﬁcacy and mech-
anism of action in domestic animals remain unclear because of
some inconsistent experimental results (Gaggia et al., 2010; Allen
et al., 2013). Additionally, lack of safety evaluation and poor sta-
bility also limited the practical use of pre- and pro-biotic as feed
additives.
IMPROVEMENT OF ENVIRONMENT
According to a report of Center for Food Safety (CFS, 2013) and
Food and Agriculture Organization (FAO, 2006), housing stress,
due to over-crowding of animals, creates sweeping and devastat-
ing impacts on the natural and human environment leading to
global warming, land degradation, air and water pollution, and
loss of biodiversity. Livestock waste is one of the major sources
of greenhouse gases, as the abnormal fermentation of gastroin-
testinal tract contents can produce lots of methane, ammonia,
carbon dioxide, as well as stench gases (e.g., nitrate, ethylene acid,
methyl mercaptan, hydrogen sulﬁde, methylamine, and trimethy-
lamine). Fecal waste of animals generally contains 24% protein
and 6.1∼17.96% amino acids. Nitrogen and phosphorus in the
waste lead to environmental pollution, water eutrophication and
ecological imbalance.
Some antimicrobials in feed could inhibit the abnormal fer-
mentation and consequently, reduce the emission of greenhouse
gases (mainly CH4). For example, ionophores (monensin, lasa-
locid, and salinomycin), amoxicillin, ovoparcin, nigericin, or
laidlomycin inhibited rumen microbial fermentation at different
levels and thus, reduced the proportion of volatile fatty acids
(VFA) and methane (Van Nevel and Demeyer, 1995; Fellner
et al., 1997; Domescik and Martin, 1999). Since the mid-1970s,
ionophorous antibiotics have been widely used as feed additives in
ruminants due to their favorable effects on rumen fermentation
and methane reduction (Kobayashi, 2010). Due to the efﬁcacy
and affordable price, ionophores have widely been used to reduce
methane emission from livestock (Hook et al., 2010; Kobayashi,
2010). When ionophores (monensin and lasalocid) were mixed
with rumen microorganisms in vitro, these inhibited methane
by 50 and 44%, respectively and decreased NH3 by more than
50% (Russell and Jeraci, 1984). In rumen models, ionophores
(monensin, lasalocid, and salinomycin) inhibited 10∼20% lipol-
ysis and biological hydrogenation (Van Nevel and Demeyer, 1977,
1995). The effects of the antibiotics on the abatement of methane
production may be attributed to a selective antimicrobial action
on rumen microbes (protozoa, ruminococci, streptococci, and
lactobacilli). Addition of monensin and lasalocid in cow forage
killed 82.5 and 76.8%, respectively, of the intestinal ciliated pro-
tozoa in rumen and hence, reduced the production of methane
and VFAs (acetic acid and propionic acid) by ciliates (Guan et al.,
2006). Generally, the gas production was reduced from 4 to 31%
by monensin (Schelling, 1984; Rumpler et al., 1986; Kobayashi,
2010). A recent report has indicated that long-term administra-
tion of monensin in dairy cattle steadily reduced methane by 7%
and this reduction persisted for 6 months with no adverse effect
on milk yield (Odongo et al., 2007). However, previous studies
also found that both, the methane level and protozoal number,
returned to baseline after long-term administration of high con-
centration of the antibiotic (Guan et al., 2006; Odongo et al., 2007;
Hook et al., 2010). The efﬁciency of monensin supplementation,
for reducing methane output in ruminants, appeared to be differ-
ent in the degree of abatement depending on the diet and animal
used (Guan et al., 2006; Odongo et al., 2007; Hook et al., 2010).
Effect of the drug on the methane levels in rumen was closely
related to the ciliated, protozoal population. Microbial consor-
tia, like protozoal population, in the ruminant gut may adapt
to the antibiotics leading to the recovery of methane production
yield, in case of a long-term usage. Therefore, the ciliates in the
rumen may impact the outcome of antimicrobial supplementa-
tion, with adaptation being a possibility (Guan et al., 2006; Hook
et al., 2010).
Through manure application, antibiotics got released into soil
and could be absorbed by plants in arable land. Certain species
of plants have the ability to bio-accumulate sulfamethoxine in
their roots and stems, and this bioaccumulation was often higher
in roots than in stems (Sarmah et al., 2006). Low concentrations
of chlortetracycline and oxytetracycline in the soil media could
markedly affect plant growth and development (Sarmah et al.,
2006). However, there was a large variation in sensitivity among
plant species to the soil used as the growth media (Sarmah et al.,
2006).
When residues seeped into water, certain antimicrobials also
played signiﬁcant role in the prevention of water eutrophication
for aquatic animals. For example, chlortetracycline, lomeﬂoxacin
hydrochloride, and sulfamethoxazole strengthened the absorp-
tion of nitrogen and phosphorus in water by aquatic plants, and
chlortetracycline effectively removed 25% of water nitrate and
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nitrogen (Dodds et al., 1991; Jones, 2010). On the other hand,
the presence of antibiotic residues in environment may cause
some adverse impacts, like acute and chronic toxicity, during early
life stages of different aquatic organisms (Halling-Sorensen et al.,
2003; Sarmah et al., 2006).
NEGATIVE IMPACT OF ANTIMICROBIAL BAN
Ban on addition of sub-therapeutic antimicrobials in feed
appeared to result in a certain extent of recovery of some bac-
teria and some unintended impacts on animal health and welfare
(Drouin, 1999; Rose et al., 1999; Lovland and Kaldhusdal, 2001;
Jensen et al., 2003). Emergence of E. coli and Lawsonia intracel-
lularis infection in post-weaning pigs was signiﬁcantly increased
and consequently, the morbidity and mortality due to diar-
rhea were considerably increased (Casewell et al., 2003; Dibner
and Richards, 2005). In Denmark, the mortality rate in wean-
ing piglets increased from 2.7% (before the ban) to 3.5% (after
the ban) and the morbidity rate of enteric infections in post-
weaning pigs increased by 600% (Casewell et al., 2003; Dibner
and Richards, 2005). In Sweden, chronic infections due to E. coli
and L. intracellularis became more common and the mortality in
weaning pigs increased by 1.5% (Wierup, 2001; Casewell et al.,
2003).
To control animal diseases and to keep animals healthy, more
therapeutic antimicrobials had to be used after the ban. It was
reported that the usage amount of therapeutic antimicrobials
in Denmark increased by 33.6%, from 48 tons/year in 2001
to 125.5 tons/year in 2010 (DANMAP, 2010). The increased
amount of therapeutic antimicrobials was equal to or even more
than the total quantity of antimicrobials being used before the
ban (Phillips, 1999; Casewell et al., 2003; Phillips et al., 2004a,b;
Turnidge, 2004; DANMAP, 2010). As shown in Figure 1, ther-
apeutic use of tetracycline, penicillins, and macrolides markedly
increased from 28.5, 16.4, and 13.4 tons in 2001 to 35.55, 27.1,
and 16.8 tons in 2010, respectively (Phillips, 2007; DANMAP,
2010).
FIGURE 1 | Estimated total consumption (kg) of prescribed
antimicrobial agents for production animals in Denmark (data
obtained from DANMAP, 2010).
Withdrawal of low-dose antimicrobial use as feed additives
may increase the level of pathogens such as Salmonella spp.,
Campylobacter spp., Clostridium and E. coli O157 in animal gut,
boost the contamination of food and environment, and hence,
enhance the opportunities for humans to be infected by these
pathogens. Population of Campylobacter in broilers fed without
antimicrobials was threefold higher than that in the broilers fed
with any antimicrobials (Heuer et al., 2001). Incidence of food-
borne Campylobacter in EU has been increased after the ban
issue. Recovery of Clostridium from animal meat was also signif-
icantly increased in EU after its ban policy (Jones, 2000; Poduval
et al., 2000). As a consequence, clostridial infections resulted in
an outbreak affecting large human population in Demark and
pointed out the high level of threat to public health (DAN-
MAP, 2010). It is known that clostridial necrotic enteritis in
animals is suppressed by some of the banned antimicrobials (e.g.,
virginiamycin). In the absence of these antibiotics, the bacte-
rial population may increase in animal guts and colonization
may lead to poor weight uniformity and fragile intestines in
pigs and chicks. During food processing, infected animal car-
casses could be the sources of contamination for food-borne
pathogens and thereby, jeopardize food hygiene (Tice, 2001;
Russell, 2003). Bacterial contamination of meat may, therefore,
increase the risk of human infections. Contrary to EU, inci-
dence of food-borne diseases in USA was declined by 23% in
1996 and among those, the infections due to Campylobacter and
Salmonella were decreased by 30 and 17%, respectively. It was
believed that ban of virginiamycin in USA might annually con-
tribute to the death of 40,000 people, infected by Campylobacter
(Cox, 2005).
The ban may lead to increased food-borne infections and ele-
vated usage of therapeutic antimicrobials in both animals and
humans. It is noteworthy that therapeutic use of antimicrobial
agents in animals has a close relationship with the drugs used in
humans with respect to the types of drugs used (Cook, 1999).
The increased therapeutic use in animals may contribute to a
worse, drug-resistance scenario both in animals and humans. It
was noted that clinical isolates of vancomycin- or teicoplanin-
resistant Enterococci from humans were very uncommon and the
cases of quinupristin/dalfopristin-resistant Enterococcus faecium
were very rare before the ban. Similarly, resistant E. faecium bur-
den markedly increased and became a big challenge after the ban
(Phillips, 2007).
After the European ban on growth-promoting antibiotics, it
was found that FCR (total kg of feed used per grow out/total
kg of live weight per grow out) in broiler was decreased by
0.016 kg/kg from November 1995 to May 1999 (1.78–1.796) in
Denmark. Feed efﬁciency raised to a higher value of 1.83 imme-
diately after the restrictions and more than 1.84 in late 1999
(Emborg et al., 2002; Dibner and Richards, 2005). Average daily
gain of weaning piglets in Denmark was decreased from 422 g
in 1995 to 415 g in 2001 (Casewell et al., 2003; Dibner and
Richards, 2005). Production of broilers, cattle, and dairy cows
was signiﬁcantly decreased in 2006, as shown in Figure 2. In
Sweden, weight gain of post-weaning piglets was reduced and
feed costs were signiﬁcantly increased after the abolishment of
growth-promoting antimicrobial agents (Wierup, 2001; Casewell
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FIGURE 2 | Production of food animals in Denmark from 1998 to 2010
(data obtained from DANMAP, 2010).
et al., 2003). Even after 10 years, aquaculture production in
Sweden was unable to return to the past level (Casewell et al.,
2003).
If the use of antimicrobials is banned in USA, FCR may decline
by 5% and more than 1100 km2 area is required to plant corn
and soybeans to meet the demand of feedstuff production. Con-
sequently, required facilities for livestock and poultry production
will be correspondingly increased by 100 million m2, and farming
area will also be increased by 500 million m2 to obtain the current
level of animal production (Casewell et al., 2003). It was esti-
mated that withdrawal of antimicrobial growth promoters might
lead to a loss of 5∼10 or even 40 dollars/pig in USA (Matthews,
2001). It does not seem to be a high cost for the developed coun-
tries but what will be the consequences if these antimicrobials
are banned worldwide? It was also investigated that 25% of the
current poultry industry and $3 billions would be additionally
required to attain the current annual animal production (Rode-
hutscord et al., 2002; IFAH-EuroP, 2005). In conclusion, keeping
in view the ever-increasing world population and its demands,
more food animals should be raised to meet the food supply
demand in the case of growth-promoting antibiotics remain pro-
hibited and this increased number of animals will again lead to
the increase in greenhouse gas emission and deeper environmental
pollution.
RISKS OF ANTIMICROBIALS
INHIBITION OF BIOGAS PRODUCTION
Following the wide use of antimicrobial drugs in intensive animal
production for growth promotion and prevention or treatment
of disease, a large proportion of ingested drugs are excreted in
manure and end up with livestock wastewater. Excreted antibi-
otics in the environment may partially inhibit methanogenesis in
anaerobicwaste-storage facilities, commonlyused atConcentrated
Animal Feeding Operation (CAFOs), and thus, decrease the rate
at which bacteria metabolize animal waste products (Loftin et al.,
2005; Sarmah et al., 2006).
During the anaerobic digestion of livestock waste, certain
antimicrobials, including amoxicillin, aureomycin, oxytetracy-
cline, thiamphenicol, ﬂorfenicol, sulfadimethoxine, and tylosin,
had inhibitory effects on methane production (Lallai et al., 2002;
Sun et al., 2009; Shi et al., 2011; Amin et al., 2012). However,
no inhibitory effect but a stimulus for methane production was
observed during anaerobic digestion of piggery wastewater in the
presence of 10 mg/L ﬂorfenicol, amoxicillin, aureomycin, and sul-
fadimethoxine, while only the combination of high concentration
of certain antimicrobials (130 mg/L ﬂorfenicol, 210mg/L amoxi-
cillin, 10mg/L doxycycline, and 210mg/L sulfadimethoxine) could
decrease the methane production rate (Sun et al., 2009). Biogas
volume, produced from per unit weight of biomass, was decreased
with increasing concentrations of antibiotics, such as oxytetracy-
cline, amoxicillin, and tylosin, and the inhibitory concentrations
of oxytetracycline, amoxicillin, and tylosin were 8000, 9000, and
9000 mg/L, respectively (Amin et al., 2012). Only high concen-
tration of thiamphenicol (160 mg/L), amoxicillin (120 mg/L),
tetracycline (50 mg/L), and sulfamethoxydiazine (50 mg/L) had
inhibitory effect on biogas production in the anaerobic digestion
of pig waste slurry (Lallai et al., 2002; Shi et al., 2011). Actually, it
is too difﬁcult to attain those high concentrations of antibiotics in
the excreta.
ANTIMICROBIAL RESISTANCE CONCERNS
Misuse and overuse of antimicrobial may culminate in the devel-
opment of drug-resistant pathogens resulting in poor response
to treatment. Long-term and low-level exposure to antimicro-
bials may have greater selective potential than short-term and
full-dose therapeutic use. A study observed that the percentage
of tetracycline resistance genes in the fecal ﬂora of convention-
ally raised feedlot steers was signiﬁcantly higher than that in fecal
samples from antimicrobial-free cattle (Harvey et al., 2009). Addi-
tionally, use of single antimicrobial may induce cross-resistance
to antimicrobials used for animal and human medical therapy.
For example, chlortetracycline use in growth rations was associ-
ated with ampicillin and tetracycline resistance in generic fecal E.
coli, isolated from swine farms (Varga et al., 2009). Addition of
chlortetracycline and sulfamethazine in cattle feed may be asso-
ciated with higher prevalence (three to four fold greater than the
control) of ampicillin- and tetracycline-resistant E. coli, isolated
from the feces of treated animals (Alexander et al., 2010). There-
fore, how to use antimicrobials, for effective treatment of bacterial
and parasitic infections in food-producing animals, became the
most important question for their use by avoiding the resistance
development.
Regarding public health risk, more concern has been raised
for the use of antibiotics in animals that may represent a poten-
tial threat to human health because the resistant pathogens in
animals may transmit to humans and cause treatment failure
of human medicines. A longitudinal study of the relationship
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between antimicrobial-resistant E. coli from human wastewa-
ter and swine fecal samples reported that the use of injectable
(e.g., ceftiofur sodium) or oral (e.g., chlortetracycline) antibi-
otics may contribute to the high levels of E. coli resistance in
swine and human isolates. Thus, slaughter plant workers may
be at higher risk of carrying multidrug-resistant E. coli as com-
pared to workers dealing with other animals (Alali et al., 2008).
A study analyzed the correlation between E. coli isolates from
human blood stream and food-producing animals (poultry, pigs,
and cattle) for the prevalence of antimicrobial resistance in 11
countries during 2005–2008. Results revealed that there were
strong and signiﬁcant correlations between the strains from ani-
mals (especially poultry and pigs) and humans for resistance to
multiple drugs (especially ampicillin, aminoglycoside, and ﬂuoro-
quinolone; Vieira et al., 2011). However, there is not enough and
direct evidence to support the hypothesis that a large proportion of
resistant isolates in humans be derived from animal source foods.
Some recent studies suggested that some resistant isolates from
humans were more easily transmitted from companion animals
(having close contact) or birds (by bird droppings especially dur-
ing their migration; Haenni et al., 2012; Loncaric et al., 2013). The
resistant bacteria may also be released into the environment by
humans and then transferred into new hosts in the environment
(Hower et al., 2013; Verkade and Kluytmans, 2013). Based on the
results of some current studies, Dr. Hurt pointed out that pub-
lic health risk due to infected animals need more attention than
antibiotic resistance concern (Hurd et al., 2008, 2012). Therefore,
further efforts are required for the risk assessment of antimicro-
bial use in food animals to check their potential impact on public
health.
POSITIVE EFFECTS OF ANTIMICROBIAL BAN
Aim for thewithdrawal of antimicrobial agents usedwas to prevent
humans and animals from drug resistance. The ban on antimi-
crobial growth promoters led to decreased drug resistance in
some bacteria. For example, according to report from the DAN-
MAP, substantial reductions (from 80 to 2%) in the prevalence
of vancomycin-resistant enterococci (VRE) were observed after
ban of avoparcin as the growth promoter during 1995 and 2010
(DANMAP, 2010). E. faecium and Enterococcus faecalis are two
of the most common Enterococci species and in Europe, only
vancomycin-resistant E. faecium (VREF) is highly prevalent in
poultry (Werner et al., 2008). VREF was still present as a threat
in the food chain even after 15 years of the EU ban on avoparcin
and could be detected in 47% of the broiler feces with a selec-
tive enrichment method (Garcia-Migura et al., 2007; DANMAP,
2010).
The ban on tylosin as the growth promoter had a remark-
able effect on the level of macrolide (erythromycin) resistance
in Campylobacter coli (most common Campylobacter species in
pigs) from pigs as it decreased from 66 to 20% in Denmark
between 1998 and 2005 (Hammerumet al., 2007). However,DAN-
MAP data showed that during 2006–2010, macrolide resistance
in C. coli varied within the range of 10–20% without signiﬁcant
reduction (DANMAP, 2010). In contrast to EU, macrolides (e.g.,
tylosin) in USA had been approved for usage in food-producing
animals as growth promoter for decades. Macrolide resistance
in C. coli isolated from poultry, although higher than that in
C. jejuni, has no signiﬁcant change (5–20%) between 2002 and
2010.
Use of enroﬂoxacin in poultry was withdrawn by US-FDA in
2005 because it was supposed to induce ﬂuoroquinolone resistance
in Campylobacter and Salmonella from poultry and contribute
to the antibiotic treatment failure in humans [Food and Drug
Administration (FDA),1998, 2002; Nelson et al., 2007]. Afterwith-
drawal of enroﬂoxacin from poultry, the rate of ﬂuoroquinolone
resistance in Campylobacter and Salmonella had been reduced in
chicken during 2005–2007 (NARMS, 2010). Human clinicians
also observed a reduction in domestically acquired Campylobacter
and Salmonella infections with decreased susceptibility to ﬂu-
oroquinolones, and it was thought to be a great achievement
regarding public health (Nelson et al., 2007). However, the inci-
dence rate of ﬂuoroquinolone-resistant C. jejuni, from chicken
breast, again increased (15.2∼22.5%) in 2008–2010. Similarly,
ﬂuoroquinolone-resistant Campylobacter from broilers was also
raised from 5.3 to 8.6% and from 0.8 to 7.7% in Denmark and
Japan, respectively (CIPARS,2008; JVARM,2008;DANMAP,2010;
NARMS, 2010).
CONCLUSION AND PERSPECTIVES
Deﬁnite targeting of pathogens, well-known mechanisms of activ-
ity, and preferable stability for administration are the unique
advantages of antimicrobial use in food-animals for the prevention
and treatment of bacterial and parasitic diseases, improvement
of animal production performance, and protection of environ-
ment and public health. Withdrawal of antimicrobial use from
food-producing animals may bring adverse effects on the produc-
tion of food derived from animals and thus, on public health.
EU banned only low-dose antibiotics (5∼40 ppm) for their use
as growth promoters in food animals. Until now, without help-
ing for the cause, it led to some negative effects on food animal
production and public health. What will happen if the antimicro-
bial agents are banned worldwide, especially in some developing
countries with rapid increase in human population and food
demand?
As a double-edged sword, non-rational uses of veterinary
antimicrobials may result in pressure selection of antimicro-
bial resistant pathogens which may endanger both the ani-
mal and public health. Additionally, the presence of antibiotic
residues in the environment, associated with overuse of antimi-
crobial drugs, may adversely inﬂuence the manure treatment
systems by inhibition of biogas production. An economic analysis
about use and withdrawal of antimicrobial growth promot-
ers in USA revealed that the withdrawal may cause increased
cost ($10/person) for food consumption and antibiotic-resistant
infections cost the US healthcare system an excess of $20
billion ($60/person) annually (APUA, 2010). However, it is
unknown that how much of these $20 billion is due to antimi-
crobial resistance associated with their use in food-producing
animals.
Recently, the US FDA has also proposed restrictions on the
antimicrobial growth promoters because some available infor-
mation and evidences suggested that the sub-therapeutic use
may increase the risk of antimicrobial resistance. To make wise
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strategies for controlling antimicrobial resistance and effectively
respond to the public health concerns associated with drug resis-
tance, FDA believes that it is very important and imperative
to consider how antimicrobial drugs are being used and how
to address their injudicious uses in nature. Only rational use
and effective regulation can ensure a beneﬁt–risk balance of the
antimicrobial application in animal production. However, long-
term policies will be required for the international regulation of
antibiotic use in food-producing animals.
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